These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29109932)

  • 1. International Council for Harmonisation E6(R2) addendum: Challenges of implementation.
    Bhatt A
    Perspect Clin Res; 2017; 8(4):162-166. PubMed ID: 29109932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality Tolerance Limits: Framework for Successful Implementation in Clinical Development.
    Bhagat R; Bojarski L; Chevalier S; Görtz DR; Le Meignen S; Makowski M; Nadolny P; Pillwein M; Suprin M; Turri S
    Ther Innov Regul Sci; 2021 Mar; 55(2):251-261. PubMed ID: 32885397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stakeholders' recommendations for revising Good Clinical Practice.
    Corneli A; Forrest A; Swezey T; Lin L; Tenaerts P
    Contemp Clin Trials Commun; 2021 Jun; 22():100776. PubMed ID: 33997463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stakeholders' views on the most and least helpful aspects of the ICH E6 GCP guideline and their aspirations for the revision of ICH E6(R2).
    Dombeck C; Swezey T; Forrest A; Tenaerts P; Corneli A
    Contemp Clin Trials Commun; 2022 Oct; 29():100983. PubMed ID: 36111176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The revamped Good Clinical Practice E6(R3) guideline: Profound changes in principles and practice!
    Bhatt A
    Perspect Clin Res; 2023; 14(4):167-171. PubMed ID: 38025289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. General Principles for the Education and Training of GCP Inspectors: The Outcome of Discussions by International Regulatory Experts in the Discussion Group on the ICH E6 Guideline.
    Uyama Y; Yamazaki E; Clark K; Wang CY; Woro E; Tong FY; Sachidanandan S; Rodriguez A; Oh H; Saleh K; Cirunay J; Wapeewuttikorn A; Rogov E; Alshahwan KW; Herrera I; Mthetwa J; Fakudze F; Osawa T
    Ther Innov Regul Sci; 2015 Mar; 49(2):249-253. PubMed ID: 30222411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A note on the draft International Council for Harmonisation guidance on estimands and sensitivity analysis.
    Mehrotra DV
    Clin Trials; 2019 Aug; 16(4):339-344. PubMed ID: 30977390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework?: Insights and Perspectives From the National Institute for Health and Care Excellence and Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen on the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 (R1) Addendum.
    Morga A; Latimer NR; Scott M; Hawkins N; Schlichting M; Wang J
    Value Health; 2023 Feb; 26(2):234-242. PubMed ID: 36150999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toolkit for ICH E6 (R2) Quality Risk Management for Small to Medium Size Companies.
    Della-Coletta A; Katz T; Kupka K; Mohan S; Novak KA; Petrizzo M; Silvers SA
    Ther Innov Regul Sci; 2020 Jul; 54(4):900-921. PubMed ID: 32557313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey Results and Recommendations from Japanese Stakeholders for Good Clinical Practice Renovation.
    Nakamura K; Ozawa H; Shibata T; Ushirozawa N; Hata T; Okita N; Fuse N; Sato N; Ikeda K; Hanaoka H; Maruyama T; Wada M; Shimizu S; Kasai H; Yamamoto Y; Sakurai J; Todaka K; Tashiro S; Yamamoto H
    Ther Innov Regul Sci; 2022 Mar; 56(2):220-229. PubMed ID: 34787814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
    Browne LH; Graham PH
    Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2C(R2) Periodic Benefit-Risk Evaluation Report and E2C(R2) Periodic Benefit-Risk Evaluation Report--Questions and Answers; International Council for Harmonisation; Guidances for Industry; Availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2016 Jul; 81(138):46938-40. PubMed ID: 27459749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Conference on Harmonisation; addendum to International Conference on Harmonisation Guidance on S6 Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2012 May; 77(97):29665-6. PubMed ID: 22616137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trials and the new good clinical practice guideline in Japan. An economic perspective.
    Ono S; Kodama Y
    Pharmacoeconomics; 2000 Aug; 18(2):125-41. PubMed ID: 11067647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the quality conduct and efficiency of clinical trials with training: Recommendations for preparedness and qualification of investigators and delegates.
    Bechtel J; Chuck T; Forrest A; Hildebrand C; Panhuis J; Pattee SR; Comic-Savic S; Swezey T
    Contemp Clin Trials; 2020 Feb; 89():105918. PubMed ID: 31881391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Good Clinical Practice guideline and its interpretation - perceptions of clinical trial teams in sub-Saharan Africa.
    Vischer N; Pfeiffer C; Joller A; Klingmann I; Ka A; Kpormegbe SK; Burri C
    Trop Med Int Health; 2016 Aug; 21(8):1040-1048. PubMed ID: 27260671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A constructive critique of the
    Scharfstein DO
    Clin Trials; 2019 Aug; 16(4):375-380. PubMed ID: 31184495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New Japanese GCP--from the standpoint of a sponsor].
    Ebi O
    Gan To Kagaku Ryoho; 1998 Apr; 25(5):650-62. PubMed ID: 9571962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
    Ebi O
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.